Childhood Cancer

You are here

Impact of Pediatric Germline Testing in a Pediatric Cancer Predisposition Clinic

Institution: 
Children's Hospital of Philadelphia
Researcher(s): 
Lisa Schwartz, PhD
Grant Type: 
Psychosocial Family Impact Grant
Year Awarded: 
2018
Type of Childhood Cancer: 
General Pediatric Cancer
Project Description: 

Background
Growing evidence highlights that at least 15% of childhood cancer patients harbor a germline cancer predisposition, increasing the risk for developing cancer by over 10,000 fold. As such, there are increasing efforts to assess newly diagnosed youth with cancer or suspected predisposition (via family history or profiles of symptoms/clinical features) for germline predisposition. However, the research on psychosocial and behavioral outcomes of pediatric germline testing have not kept pace with advances in the testing. We propose a prospective, mixed methods, multi-informant study to assess the experience of testing and subsequent impact on caregivers and youth probands. Specifically, we aim to evaluate the perceived experience and psychosocial impact of germline testing, evaluate behavioral and familial outcomes for those with positive findings, and use qualitative interviews to further evaluate experiences and impact for those with cancer predisposition. 

Project Goal:
To accomplish these aims, we will follow 150 families with a child that will be tested for suspected cancer predisposition. More than one caregiver will be invited to participate, as well as the child’s proband if 12 years or greater. Measures will be completed within 1 month before testing, within 1 month post-return of results, and 6 months after return of results. A subsample will participate in interviews. We will summarize and integrate qualitative and quantitative data across participants (mothers, fathers, AYA) using mixed methods informational matrices and provide recommendations for future supportive care of those with significant germline findings.

Co-funded by: 
Northwestern Mutual Foundation